Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.27B |
| 2 |
Zimmer Biomet
ZBH
|
+$3.42B |
| 3 |
TransUnion
TRU
|
+$1.8B |
| 4 |
Qualcomm
QCOM
|
+$587M |
| 5 |
Alibaba
BABA
|
+$434M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$1.06B |
| 2 |
Pfizer
PFE
|
+$895M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$631M |
| 4 |
RTX Corp
RTX
|
+$546M |
| 5 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$516M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 8.41% |
| 2 | Healthcare | 8.04% |
| 3 | Technology | 7.66% |
| 4 | Energy | 6.94% |
| 5 | Consumer Discretionary | 6.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
S
3951
PUT
DELISTED
Sprint Corporation
S
| $1.71M | ﹤0.01% |
374,800
+36,900
| +11% | +$178K |
|
|
CPLA
3952
DELISTED
Capella Education Company
CPLA
| $1.71M | ﹤0.01% |
31,847
-13,661
| -30% | -$789K |
|
3953
Gerdau
GGB
$9.74B
| $1.71M | ﹤0.01% |
893,258
-90,959
| -9% | -$219K |
|
|
TMHC
3954
DELISTED
Taylor Morrison
TMHC
| $1.71M | ﹤0.01% |
83,820
-76,652
| -48% | -$1.52M |
|
3955
CALL
Louisiana-Pacific
LPX
$5.06B
| $1.71M | ﹤0.01% |
100,100
-61,200
| -38% | -$1.04M |
|
|
VIRX
3956
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $1.7M | ﹤0.01% |
2,696
+2,083
| +340% | +$1.11M |
|
|
ANFI
3957
PUT
DELISTED
AMIRA NATURE FOODS LTD
ANFI
| $1.7M | ﹤0.01% |
148,000
+143,300
| +3,049% | +$1.45M |
|
|
HIFR
3958
DELISTED
InfraREIT, Inc.
HIFR
| $1.7M | ﹤0.01% |
59,984
-9,593
| -14% | -$297K |
|
3959
PUT
Sanofi
SNY
$103B
| $1.7M | ﹤0.01% |
34,300
+13,100
| +62% | +$664K |
|
3960
American States Water
AWR
$3.36B
| $1.7M | ﹤0.01% |
45,368
-2,395
| -5% | -$92.3K |
|
3961
PUT
Allstate
ALL
$68B
| $1.69M | ﹤0.01% |
26,100
-14,000
| -35% | -$960K |
|
3962
CALL
Masco
MAS
$14.1B
| $1.69M | ﹤0.01% |
72,149
-33,230
| -32% | -$787K |
|
|
K
3963
PUT
DELISTED
Kellanova
K
| $1.69M | ﹤0.01% |
28,649
+3,195
| +13% | +$191K |
|
|
HEES
3964
DELISTED
H&E Equipment Services
HEES
| $1.69M | ﹤0.01% |
84,423
+6,634
| +9% | +$159K |
|
3965
S&T Bancorp
STBA
$1.84B
| $1.68M | ﹤0.01% |
56,840
-1,893
| -3% | -$53K |
|
3966
CALL
Fossil Group
FOSL
$293M
| $1.68M | ﹤0.01% |
24,200
-41,300
| -63% | -$3.21M |
|
|
RYL
3967
CALL
DELISTED
RYLAND GROUP INC
RYL
| $1.68M | ﹤0.01% |
36,200
-7,400
| -17% | -$329K |
|
|
NXTM
3968
DELISTED
NxStage Medical Inc.
NXTM
| $1.68M | ﹤0.01% |
117,416
+77,819
| +197% | +$1.32M |
|
3969
Element Solutions
ESI
$8.95B
| $1.68M | ﹤0.01% |
65,481
-538
| -0.8% | -$14.5K |
|
|
CMCSK
3970
CALL
DELISTED
COMCAST CORP SPL A (NEW)
CMCSK
| $1.67M | ﹤0.01% |
27,900
+5,300
| +23% | +$318K |
|
3971
PUT
Lincoln National
LNC
$8.73B
| $1.67M | ﹤0.01% |
28,200
-10,800
| -28% | -$632K |
|
|
MCRN
3972
DELISTED
Milacron Holdings Corp.
MCRN
| $1.67M | ﹤0.01% |
+84,824
| New | +$1.67M |
|
|
PERY
3973
DELISTED
Perry Ellis International Inc
PERY
| $1.67M | ﹤0.01% |
70,065
+37,091
| +112% | +$916K |
|
3974
CALL
State Street SPDR S&P Biotech ETF
XBI
$9.95B
| $1.67M | ﹤0.01% |
19,800
| – | – |
|
3975
Kearny Financial
KRNY
$604M
| $1.66M | ﹤0.01% |
+149,072
| New | +$1.55M |
|
Similar funds
Goldman Sachs's Q2 2015 Portfolio in Review
As of Q2 2015, Goldman Sachs held 7,731 positions worth $323B, up 3.7% from $311B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Goldman Sachs deployed $13.1B of net new capital in Q2 2015, opening 673 new positions and adding to 3,224 existing holdings. Its largest new stake was TransUnion: 72,355,340 shares worth $1.82B.
By sector, the portfolio is most concentrated in Financials at 8.4% of assets, up from 8% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Gilead Sciences, an estimated $1.06B trimmed.
- Goldman Sachs's largest Q2 2015 buy was TransUnion: 72,355,340 shares worth $1.82B.
- Goldman Sachs added most to State Street SPDR S&P 500 ETF Trust in Q2 2015, an estimated $4.27B increase.
- Goldman Sachs's biggest Q2 2015 reduction was Gilead Sciences, cutting an estimated $1.06B.
- Goldman Sachs fully exited LORILLARD INC COM STK in Q2 2015, selling an estimated $386M.
- Goldman Sachs's ten largest holdings make up 14% of its $323B portfolio in Q2 2015.
- Goldman Sachs opened 673 new positions and closed 497 in Q2 2015.
- Goldman Sachs's portfolio value rose 3.7% quarter-over-quarter to $323B.
Based on Goldman Sachs's 13F filing for Q2 2015, filed 14 Aug 2015.